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INTRODUCTION: Being overweight or obese is associated with a higher rate of survival in patients with advanced chronic ob-
structive pulmonary disease (COPD). This paradoxical relationship indicates that the influence of nutritional status on functional 
parameters should be further investigated. 
OBJECTIVE: To investigate the impact of nutritional status on body composition, exercise capacity and respiratory muscle strength 
in severe chronic obstructive pulmonary disease patients.
METHODS: Thirty-two patients (nine women) were divided into three groups according to their body mass indices (BMI): over-
weight/obese (25 ≤ BMI ≤ 34.9 kg/m2, n=8), normal weight (18.5 ≤ BMI ≤ 24.9 kg/m2, n=17) and underweight (BMI <18.5 kg/m2, 
n=7). Spirometry, bioelectrical impedance, a six-minute walking distance test and maximal inspiratory and expiratory pressures 
were assessed. 
RESULTS: Airway obstruction was similar among the groups (p=0.30); however, overweight/obese patients had a higher fat-free 
mass (FFM) index [FFMI=FFM/body weight2 (mean±SEM: 17±0.3 vs. 15±0.3 vs. 14±0.5 m/kg2, p<0.01)], exercise capacity (90±8 
vs. 79±6 vs. 57±8 m, p=0.02) and maximal inspiratory pressure (63±7 vs. 57±5 vs. 35±8 % predicted, p=0.03) in comparison to 
normal weight and underweight patients, respectively. In addition, on backward multiple regression analysis, FFMI was the unique 
independent predictor of exercise capacity (partial r=0.52, p<0.01). 
CONCLUSIONS: Severe chronic obstructive pulmonary disease (COPD) patients who were overweight or obese had a greater 
FFM, exercise capacity and inspiratory muscle strength than patients with the same degree of airflow obstruction who were of 
normal weight or underweight, and higher FFM was independently associated with higher exercise capacity. These characteristics 
of overweight or obese patients might counteract the drawbacks of excess weight and lead to an improved prognosis in COPD. 
KEYWORDS: Chronic obstructive pulmonary disease; Body mass index; Body composition; fitness; Respiratory muscle strength.
INTRODUCTION
There is an association between body mass index (BMI) 
and increased early mortality in the general population.1,2 
However, while in some studies, both low and high BMI 
have been associated with increased mortality (i.e., mortality 
plotted as a function of BMI has a U-shaped curve),1,2 other 
studies have shown an association between high BMI and 
increased mortality (i.e., mortality plotted as a function 
of BMI has a J-shaped curve).1,2 In this sense, subjects 
with low BMI present with a higher risk of death due to 
cerebrovascular disease, pneumonia, and diseases of the 
central nervous system.1,2 On the other hand, increased fat 
mass (FM) is associated with the development of several 
chronic diseases, particularly those of the cardiovascular 
system.1,2 
Patients with chronic obstructive pulmonary disease 
(COPD) generally present with difficulty in breathing,3 
inadequate dietary intake due to difficulties in ingesting 
food4 and excessive apoptosis of skeletal muscle due to 600
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increased systemic inflammation.5 These and other factors 
lead to a negative energy balance and decreasing body 
weight over the course of the disease, with the reduction in 
body weight occurring mainly as a result of a decrease in 
skeletal muscle mass.6,7 It has been shown that the BMI is 
an independent predictor of mortality in COPD patients.6,7 
Nonetheless, the association between BMI and mortality 
seems to differ according to the severity of COPD. Patients 
with mild COPD present a bi-modal association between 
BMI and mortality (i.e., mortality plotted as a function 
of BMI has a U-shaped curve), with the lowest risk of 
death occurring in normal weight to overweight patients. 
Among patients suffering from severe COPD, mortality 
rate decreases with increasing BMI (i.e., overweight and 
obese patients have lower mortality rate).8-10 The observed 
lower risk of death in overweight and obese patients with 
COPD has been called “the obesity paradox”;11 although its 
mechanism is still unknown, the obesity paradox seems to be 
partly related to the presence of higher fat-free mass (FFM) 
in these patients.6
Exercise intolerance is a major symptom of patients 
with COPD.12 Its cause has been shown to be multifactorial 
and to depend on impairments in airway flow, pulmonary 
mechanics, metabolic pathways, gas exchange, cardiac 
performance, respiratory and peripheral muscles and other 
factors.13 In this context, various studies have investigated 
the influence of nutritional status on exercise capacity; it 
is generally agreed that patients with a low BMI, which is 
most often due to low FFM, show lower exercise capacity 
on submaximal and maximal exercise tests.8,14-20 However, 
most of these studies investigated severe COPD patients who 
were underweight or of normal weight.15,16,19 Some studies 
have included overweight or obese patients, but they did not 
analyze these patients separately.8,14,18,21 
The few previous studies that present data on the 
influence of being overweight or obese on the exercise 
capacity of patients with severe COPD report conflicting 
results. For example, Esnner et al.20 showed that obese men 
and women presented lower exercise capacity than normal 
weight counterparts independent of age, height, FEV1/FVC 
ratio, race, education and smoking. However, these authors 
included patients with mild to severe COPD and did not 
use the degree of airway obstruction [forced expiratory 
volume at 1 s (FEV1)] in the adjusted models. Ischaki et al.17 
showed a positive association between BMI and exercise 
capacity in patients with mild to severe COPD; however, 
their results show no clear association between nutritional 
status and exercise capacity in severe COPD patients who 
are overweight or obese. Thus, the influence of nutritional 
status on the exercise capacity of overweight or obese COPD 
patients is still unknown. 
Our aim was to investigate the impact of nutritional 
status on body composition, exercise capacity and 
respiratory muscle strength in patients with severe COPD. 
We hypothesized that patients who were overweight or 
obese would have a greater FFM than patients who were 
of normal weight or underweight. Considering that the 
major contributor to FFM is skeletal muscle mass, we 
hypothesized that a greater FFM would lead to greater 
exercise capacity, in part due to greater respiratory muscle 
strength.
METHODS
Sample
Thirty-two patients (nine women) with severe COPD 
participated in this prospective cross-sectional study. The 
patients were enrolled at the pulmonary outpatient clinic 
of the University Hospital of the Londrina State University. 
The diagnosis of COPD was based on past smoking history, 
clinical evaluation and pulmonary function tests showing 
irreversible airflow obstruction.12 All patients with COPD 
were in a stable state at study entry (no exacerbations in the 
last three months that required a change in medication or 
hospital admission), were not currently smoking and were 
undergoing standard pharmacological treatment for COPD.12 
None of the patients were undergoing long-term oxygen 
therapy. The classification of COPD severity followed the 
GOLD guidelines,12 i.e., severe COPD represented FEV1 < 
50% of predicted value. Patients with orthopedic, neurologic 
or unstable cardiac diseases that might interfere with the 
results were excluded. The patients were divided into 
three groups according to the World Health Organization 
stratification of BMI:22 overweight/obese (BMI between 
25 and 29.9 kg/m2, n = 6; BMI between 30 and 34.9 kg/
m2, n = 2), normal weight (BMI between 18.5 and 24.9 kg/
m2, n = 17) and underweight (BMI < 18.5 kg/m2, n = 7). 
Overweight and obese patients were analyzed together due 
to the small number of obese patients in our sample. The 
ethics committee of the North Paraná University Hospital 
approved the research protocol and a written consent form 
was obtained for each patient.
Spirometry
Spirometry was performed using a turbine portable 
spirometer (Pony, Cosmed, Rome, Italy) according to 
American Thoracic Society guidelines.23 The FEV1, forced 
vital capacity (FVC) and maximal voluntary ventilation 
(MVV) were obtained and expressed as percentage of 
predicted according to Knudson et al.24601
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Anthropometry
Body weight was measured on a calibrated balance to the 
nearest 0.1 kg while patients were barefoot and wearing light 
clothing (Filizola model 31, Filizola, São Paulo, SP, Brazil). 
Body height was measured to the nearest 0.5 cm while 
patients were barefoot and standing with their backs and 
heels touching a vertical bar (Filizola model 31, Filizola, São 
Paulo, SP, Brazil). BMI was calculated as weight divided by 
height squared (kg/m2).
Body Composition
Body composition was assessed by single-frequency 
bioelectrical impedance analysis (Biodynamics 310, 
Biodynamics Corporation, Seattle, WA, USA). All body 
composition measurements were performed between 
noon and 2 p.m. The patients fasted on the day that the 
measurement was performed and did not ingest coffee, 
tea, chocolate or alcoholic beverages for 48 h prior to the 
measurement. During the measurement, patients lay in a 
supine position with their limbs slightly apart from their 
bodies. Two electrodes were positioned on the dorsal 
surface of the right hand, and two additional electrodes were 
positioned on the dorsal surface of the right foot. The FFM 
was calculated using an equation that has been specifically 
validated for patients with respiratory diseases.25 FM was 
calculated as total body weight minus FFM. FFM index 
(FFMI) and FM index (FMI) were calculated by dividing 
the body weight (in kg) of FFM and FM, respectively, by 
height (in m) squared in order to adjust for body surface 
area.26 It is important to note that the known prerequisites for 
the use of bioelectrical impedance analysis, which include 
patient preparation prior to the measurement, adaptation of 
equations used to transform the measured resistance into 
FFM or total body volume and testing of the validity of the 
use of these equations in the populations for which they are 
intended, were followed in the present study. Under these 
conditions, bioeletrical impedance analysis measurements 
are considered accurate and comparable to other techniques 
used to assess body composition.25
Exercise Capacity
The exercise capacity was assessed by the six-minute 
walking distance test (6MWD), which is validated27 and 
reliable28 for evaluation of the exercise capacity of patients 
with COPD. The test was performed in a 15-m long and 4-m 
wide hospital corridor. All of the patients were familiarized 
with the test procedure prior to testing. Patients were 
instructed to walk as fast as possible, aiming to complete 
the longest possible distance in the allotted time. At each full 
minute during the test, the patients were verbally encouraged 
with a standardized incentive phrase. Each patient’s result 
was expressed as an absolute value (meters) and as a 
percentage of the normal values.29
Respiratory Muscle Strength
The strength of the respiratory muscles was evaluated 
by measuring the maximal inspiratory pressure (PImax) 
and maximal expiratory pressure (PEmax) using an analog 
manovacuometer built by Record® (São Paulo, SP, Brazil). 
The range of measurement was ± 150 cm H2O. The 
manovacuometer was connected to an inextensible rubber 
hose of 38 cm in length and 0.5 cm in diameter; the hose 
was connected to a mouthpiece with a 2-mm hole to avoid 
any influence of intra-oral pressure on the measurements. 
Patients were evaluated in the seated position. A nose clip was 
used to avoid air leakage through the nostrils. For the PImax 
measurement, the patients began at the residual volume level 
and performed a maximal inspiration until total lung capacity 
was reached. For the PEmax measurement, the patients began 
at total lung capacity and performed a maximal expiration 
until only residual volume remained. Maximal pressures were 
expected to be sustained for at least one second. For each 
measurement, three attempts were made and the highest value 
was used. Expected values for PImax and PEmax were calculated 
according to Black and Hyatt.30
Statistical Analysis
Data distribution was verified by the Shapiro-Wilk 
test. Only FEV1/FVC (%) and FMI presented non-
parametric distributions. The groups were compared by 
one-way ANOVA followed by the Sheffé post hoc, or, when 
necessary, by the Kruskal-Wallis test followed by multiple 
comparisons (z – values). In addition, a backward stepwise 
multiple regression analysis was performed. The intercept 
was included in the regression model. The tolerance was set 
at 0.1, the ‘F to enter’ at 4 and the ‘F to remove’ at 3.9. These 
‘F to enter and remove’ values were chosen in order to detect 
variables that were significant at p < 0.05. The walking 
distance, expressed as a percentage value, was considered 
as the dependent variable, and only the variables that 
were significantly associated with the walking distance in 
Pearson’s correlations were used in the multiple regression 
analyses. The results are presented as mean ± standard 
error of the mean (SEM). A p-value lower than 0.05 was 
considered significant in two-tailed analyses. All analyses 
were performed using STATISTICA version 7 software 
(StatSoft, Tulsa, OK, USA).602
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RESULTS
The spirometry, anthropometry, body composition, 
exercise capacity and respiratory muscle strength results 
are presented in Table 1, which is organized by the patients’ 
nutritional status. There were no statistically significant 
differences among the groups in age, height, FEV1, FEV1/
FVC or MVV. However, the overweight/obese group had 
significantly higher body weight, BMI, FFMI, FMI, walking 
distance (449 ± 36 m vs. 410 ± 32 m vs. 280 ± 37 m, 
p = 0.02; overweight vs. normal weight vs. underweight, 
respectively) and PImax compared to the normal weight and 
underweight groups. Moreover, the normal weight group 
had higher weight, BMI and FFMI in comparison to the 
underweight group. It is worth noting that the power for the 
ANOVA comparisons presented in Table 1 was as follows: 
age = 0.19, FEV1 = 0.42, FEV1/FVC = 0.64, MVV = 0.42, 
weight = 1.00, height = 0.42, BMI = 1.00, FFMI = 1.00, 
walking distance = 0.87, PImax = 0.91, PEmax = 0.26. 
The correlations between walking distance and age, 
spirometry, body composition and respiratory muscle 
strength are presented in Table 2. There were significant 
correlations between walking distance and FEV1/FVC, 
weight, BMI, FFMI and PImax. Therefore, these variables 
were used in a backward stepwise multiple linear regression 
analysis, which showed that FFMI was the unique significant 
independent predictor of walking distance (partial r = 0.52, p 
< 0.001) (Table 3). The correlation between walking distance 
and FFMI is presented in detail in Figure 1. 
DISCUSSION
The few previous studies that present data on the influence 
of being overweight or obese on the exercise capacity of 
patients with severe COPD report conflicting results.17,20 
Therefore, the present study aimed to investigate the impact of 
Table 1 - Characteristics of the patients according to their nutritional status.
Characteristics Overweight/Obese Normal weight Underweight ANOVA (p)
Sex (M/F) 6/2 11/6 6/1 -
Age (years) 63 ± 4 63 ± 2 68 ± 4 0.60
FEV1 (%) 34 ± 4 34 ± 2 27 ± 4 0.30
FEV1/FVC (%) 64 ± 6 59 ± 4 49 ± 4 0.19
MVV (%) 36 ± 4 31 ± 3 27 ± 4 0.31
Weight (kg) 80 ± 4 * † 59 ± 2 ‡ 44 ± 3  <0.01
Height (m) 1.68 ± 0.03 1.61 ± 0.03 1.61 ± 0.04 0.23
BMI (kg/m²) 28.4 ± 0.8 * † 22.0 ± 0.5 ‡ 17.1 ± 0.4  <0.01
FFMI (kg/m²) 17.3 ± 0.3 * † 15.3 ± 0.3 ‡ 13.7 ± 0.5  <0.01
FMI (kg/m²) 11.1 ± 0.9 * † 7.6 ± 0.9  3.4 ± 0.5  <0.01
Walking distance (%) 90 ± 8 * † 79 ± 6 57 ± 8 0.03
PImax (%) 63 ± 7 * † 57 ± 5  35 ± 8  0.03
PEmax (%) 62 ± 8 50 ± 5 50 ± 8 0.43
Results presented as mean ± SEM. *, p < 0.05 overweight/obese vs. normal weight; †, p < 0.05 overweight/obese vs. underweight; ‡, p < 0.05 normal 
weight vs. underweight. FEV1, forced expiratory volume at 1 s; FEV1/FVC, ratio between forced expiratory volume in 1 s and forced vital capacity; MVV, 
maximal voluntary ventilation; BMI, body mass index; FFMI, fat- free mass index; FMI, fat mass index; PImax, maximal inspiratory pressure; PEmax, maxi-
mal expiratory pressure.
Table 2 - Pearson correlation between walking distance 
(%) and age, spirometry, body composition and respiratory 
muscle strength.
Walking Distance (%)
r p
Age (years) -0.02 0.90
FEV1 (%) 0.32 0.08
FEV1/FVC (%) 0.38 0.03
MVV (%) 0.23 0.21
Weight (kg) 0.38 0.03
Height (m) 0.06 0.74
BMI (kg/m²) 0.38 0.03
FFMI (kg/m²) 0.52 <0.01
FMI (kg/m²) 0.29 0.10
PImax (%) 0.47 <0.01
PEmax (%) -0.04 0.84
FEV1, forced expiratory volume at 1 s; FEV1/FVC, ratio between forced 
expiratory volume in 1 s and forced vital capacity; MVV, maximal voluntary 
ventilation; BMI, body mass index; FFMI, fat- free mass index; FMI, fat 
mass index; PImax, maximal inspiratory pressure; PEmax, maximal expiratory 
pressure.603
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nutritional status on the body composition, exercise capacity 
and respiratory muscle strength of patients with severe COPD. 
We found that the overweight/obese patients had greater FFM, 
exercise capacity and respiratory muscle strength and that 
FFM was the main predictor of exercise capacity.
The higher exercise capacity found in this study in 
patients with severe COPD who were overweight/obese is 
supported by the results of Ischaki el al.,17 Celli et al.8 and 
Cote et al.,21 who included overweight and obese patients 
in their samples but did not analyze overweight and obese 
subjects separately from normal weight subjects. These 
studies show a positive association between BMI and 
exercise capacity. Nonetheless, it is worth noting that FFM 
and FM contribute to the BMI. Therefore, it is important 
to analyze the association between nutritional status and 
exercise capacity taking into account the contributions of 
FFM and FM separately. In this context, VanItallie et al.26 
proposed expression of FFM and FM normalized to the 
square of the height; these parameters have been designated 
FFMI and FMI, respectively. The FFMI has been shown 
to be more useful than the BMI in identifying subjects 
with protein-energy malnutrition, and it has been shown 
to be more accurate for classifying disease severity17 and 
predicting mortality in patients with COPD.6
In this context, the data obtained by our bioimpedance 
measurements demonstrated that overweight/obese patients 
presented higher FFMI and FMI in comparison to normal 
weight and underweight patients. This result is similar to 
that of Poulain et al.,31 who showed that COPD patients who 
are overweight/obese tend to present with higher FFM. In 
our study, the FFMI was the main significant predictor of 
exercise capacity in a backward multiple linear regression 
analysis. Indeed, it has previously been shown that patients 
with normal weight and depleted FFM have lower exercise 
capacity in comparison to underweight patients with 
relative preservation of FFM.32 Our results suggest that the 
overweight/obese patients in our study had higher exercise 
capacity due to their higher FFM.
The role of FFM as a determinant of higher exercise 
capacity might result from its influence on several important 
factors. Because skeletal muscle mass is the major 
contributor to FFM and because respiratory muscle 
strength has been shown to affect the exercise capacities 
of normal and underweight patients with COPD,33 we 
attempted to determine whether differences in respiratory 
muscle function could explain the observed differences in 
exercise capacity between the various groups. While we 
found that obese/overweight patients had higher respiratory 
muscle strength than patients who were underweight, no 
variable representative of respiratory muscle function was 
a significant predictor of exercise capacity. These results 
suggest that peripheral skeletal muscles may make a more 
important contribution to exercise capacity than respiratory 
muscles. However, because peripheral muscle function was 
not measured in the present study, we can only speculate 
about this contribution.
It is important to note that, for the general population, 
mechanistic studies, studies regarding metabolic risk factors 
and studies regarding cardiovascular disease and premature 
mortality have shown that a high amount of body fat is 
associated with an increased risk of cardiovascular disease 
and early mortality.34 Despite this evidence, recent studies 
indicate that exercise capacity can modulate the harm 
caused by excessive body fat. For example, McAuley et al. 
evaluated 12,417 veterans aged 40 to 70 years and showed 
that overweight and obese men had increased longevity only 
if they registered high fitness.2 Considering that exercise 
Table 3 - Partial correlations obtained with backward multiple 
regression analysis.
Walking Distance (%)
r r
Variables not in the 
equation
FEV1/FVC (%) 0.23 0.20
Weight (kg) -0.03 0.89
BMI (kg/m²) -0.03 0.90
PImax (%) 0.29 0.16
Variable in the equation
FFMI (kg/m²) 0.52 <0.01
FEV1, forced expiratory volume at 1 s; FEV1/FVC, ratio between forced 
expiratory volume in 1 s and forced vital capacity; MVV, maximal voluntary 
ventilation; BMI, body mass index; FFMI, fat- free mass index; FMI, fat 
mass index; PImax, maximal inspiratory pressure; PEmax, maximal expira-
tory pressure. FFMI was the unique significant independent predictor of 
walking distance.
Figure 1 - Association between fat-free mass index (FFMI) and exercise 
capacity. Gray circles represent patients who are overweight/obese; black 
circles represent patients who are of normal weight; white circles represent 
patients who are underweight.604
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capacity is strongly related to prognosis for several diseases 
including COPD8,21 and that the present study and others8,17,21 
have shown that overweight/obese patients present higher 
exercise capacity than normal weight or underweight 
patients, the relationship between overweight/obesity and 
exercise capacity may represent a plausible mechanism to 
explain why severe COPD patients who are overweight or 
obese have a better prognosis. We found that the overweight/
obese patients had a greater FFM and higher respiratory 
muscle strength. Because it has been shown that FFM is an 
independent predictor of death6 and that respiratory muscle 
strength is associated with better functional status, both of 
these factors could also explain why severe COPD patients 
with overweight/obesity have better prognoses.
The results of the present study should be interpreted 
in view of some limitations. Based on high-resolution 
computed tomographic scanning, loss of FFM appears to 
be more frequent in patients with emphysema-type COPD 
than in patients with chronic bronchitis.35 We were unable 
to differentiate COPD subtypes in our sample. In addition, 
because there were few obese patients in our sample, we 
analyzed them together with overweight patients. It is worth 
noting that, for the most important comparisons between 
groups, the statistical analysis of the study data possessed 
more than 80% power to detect significant differences at 
a p-value lower than 0.05. Because patients with more 
severe obesity might present with lower exercise capacity, 
lower respiratory muscle strength and other dysfunctions 
associated with metabolic syndrome that could lead to a 
worse prognosis, other studies should attempt to determine 
the degree of obesity that reflects a better functional status 
for COPD patients. Other cohort studies using mortality as 
an endpoint are necessary to confirm that FFM, exercise 
capacity and respiratory muscle strength promote longer life 
in overweight/obese severe COPD patients. 
CONCLUSIONS
Severe COPD patients who were overweight/obese 
had greater FFM, exercise capacity and inspiratory muscle 
strength than patients with the same degree of airflow 
obstruction who were of normal weight or underweight. 
Higher FFM was independently associated with higher 
exercise capacity. Considering that FFM and exercise 
capacity are independent predictors of death and that 
respiratory muscle strength is associated with functional 
capacity, our results might explain, at least in part, why 
being overweight or obese is often associated with better 
survival in patients with severe COPD.
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